Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
The company is planning to expand its plant capacity in in Vapi
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
The facility is a part of Lupin Manufacturing Solutions
KIMS already have a multi-specialty hospital and gastro unit at Vizag
The approved ANDA is therapeutically equivalent to the reference listed drug product
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Subscribe To Our Newsletter & Stay Updated
